DIAGNOSTIC PROBES AND REMEDIES FOR DISEASES WITH ACCUMULATION OF PRION PROTEIN, AND STAINS FOR PRION PROTEIN

Details for Australian Patent Application No. 2003261834 (hide)

Owner BF RESEARCH INSTITUTE, INC. DOH-URA, Katsumi

Inventors Doh-Ura, Katsumi; Kudo, Yukitsuka; Sawada, Tohru

Agent Griffith Hack

Pub. Number AU-A-2003261834

PCT Number PCT/JP03/11056

PCT Pub. Number WO2004/035522

Priority 2002-255015 30.08.02 JP; 2002-255013 30.08.02 JP; 2003-73344 18.03.03 JP; 2002-255014 30.08.02 JP

Filing date 29 August 2003

Wipo publication date 4 May 2004

International Classifications

C07C 211/48 Compounds containing amino groups bound to a carbon skeleton

A61K 031/4184

A61P 031/00 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61K 031/428 - condensed with carbocyclic rings

C07C 215/74 Compounds containing amino and hydroxy groups bound to the same carbon skeleton

A61K 031/4709 - Non-condensed quinolines containing further heterocyclic rings

A61K 031/47 - Quinolines

C07D 215/12 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 413/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 031/381 - having five-membered rings

C07D 235/14 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

A61P 043/00 Drugs for specific purposes, not provided for in groups

C07D 417/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 333/20 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 235/10 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 235/08 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

A61K 031/341 - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

C07D 307/52 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

A61K 031/437

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

G21H 005/02 Applications of radiation from radioactive sources or arrangements therefor

G21G 004/08 Radioactive sources

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 031/429 - condensed with heterocyclic ring systems

C07D 513/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

C07D 207/335 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 031/423 - condensed with carbocyclic rings

A61K 031/42 - Oxazoles

C07D 263/56 Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 263/32 Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 263/57 Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

G01N 033/566 Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

A61K 031/427 - not condensed and containing further heterocyclic rings

C07D 277/84 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 031/433 - Thiadiazoles

C07D 277/66 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 031/4245 - Oxadiazoles

C07D 277/64 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 405/04 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

27 November 2003 Complete Application Filed

  Priority application(s): 2002-255015 30.08.02 JP; 2002-255013 30.08.02 JP; 2003-73344 18.03.03 JP; 2002-255014 30.08.02 JP

10 June 2004 Application Open to Public Inspection

  Published as AU-A-2003261834

26 July 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003261835-PROCESS FOR PRODUCTION OF POLY(m-PHENYLENEISOPHTHALAMIDE) POROUS HOLLOW FIBER MEMBRANE

2003261833-APPARATUS FOR CARRYING OUT CHEMICAL PROCESS USING SET OF SOLVENTS UNDERGOING REVERSIBLE CHANGE BETWEEN MUTUAL DISSOLUTION AND SEPARATION DEPENDING ON TEMPERATURE